NCT04760236View on ClinicalTrials.gov

Immune Non-Inferiority, Safety and Lot-to-Lot Consistency of Oral Cholera Vaccine-Simplified Compared to Shanchol™

PHASE3CompletedINTERVENTIONAL
Enrollment

2,530

Participants

Timeline

Start Date

October 6, 2021

Primary Completion Date

December 22, 2022

Study Completion Date

March 21, 2023

Conditions
Cholera
Interventions
BIOLOGICAL

Oral Cholera Vaccine Simplified (OCV-S)

"* Manufacturer: EuBiologics Co., Ltd.~* Oral administration"

BIOLOGICAL

Shanchol™

"* Manufacturer: Shantha Biotechnics~* Oral administration"

Trial Locations (4)

44600

Kanti Children's Hospital, Kathmandu

Unknown

Nepalgunj medical college, Bānke

B.P.Koirala Institute of Health Sciences, Rautahat

Dhulikhel Hospital, Kavre

Sponsors

Collaborators (1)

EuBiologics Co.,Ltd
All Listed Sponsors
collaborator

EuBiologics Co.,Ltd

INDUSTRY

lead

International Vaccine Institute

OTHER

NCT04760236 - Immune Non-Inferiority, Safety and Lot-to-Lot Consistency of Oral Cholera Vaccine-Simplified Compared to Shanchol™ | Biotech Hunter | Biotech Hunter